Luca Guardabassi is Professor in Antimicrobial Resistance and Antibiosis at the University of Copenhagen. He leads a research team currently composed by 5 postdocs and 9 PhD students. His main research interests encompass evolution, host specificity, population structure and epidemiology of multidrug-resistant bacteria such as methicillin-resistant staphylococci and Escherichia coli producing extended-spectrum β-lactamase (ESBL). In recent years he has developed a strong interest in novel strategies to improve the therapeutic efficacy of existing antibiotics and reduce their selective effects in the gut microbiota. He is presently involved in 3 EU FP7 projects, coordinator of an Initial Training Network (ITN) in the area of antimicrobial drug research (
www.train-asap.eu), and principal investigator of UC-Care (www.uc-care.ku.dk), a large interdisciplinary research centre that generates knowledge and solutions to combat antimicrobial resistance in people and animals. He serves as responsible for the veterinary diagnostic laboratory at the University of Copenhagen, as advisor for the CLSI's Subcommittee on Veterinary Susceptibility Testing (VAST), and as expert for international (ISCAID) and national antimicrobial guidelines working groups.